explore -WSS

explore

author：hotspot 2025-09-06 01:59:38 - browse：24

A cloud with a medical folder on the top of an illustration is connected to other medical vectors such as a doctor on a phone screen, a health watch, and a brain chip — coverage from STAT — Adobe

Federal health technology regulators on Wednesday finalized new rules to force software vendors to disclose how artificial intelligence tools are trained, developed, and tested — a move to protect patients against biased and harmful decisions about their care.

The rules are aimed at placing guardrails around a new generation of AI models gaining rapid adoption in hospitals and clinics around the country. These tools are meant to help predict health risks and emergent medical problems, but little is publicly known about their effectiveness, reliability, or fairness.

Starting in 2025, electronic health record vendors who develop or supply these tools, which increasingly use a type of AI known as machine learning, will be required to disclose more technical information to clinical users about their performance and testing, as well as the steps taken to manage potential risks.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

knowledge

WSS

Readout Newsletter: What happened with Sarepta's Duchenne data

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

What the US credit downgrade means for the economy, your finances

Eli Lilly to pay $200M for Beam’s stake in gene

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Mega Millions pot grows to $1.25 billion after no winner

hotspot

explore

hotspot

Drug repurposing or repositioning? The language matters

5 important ways Henrietta Lacks changed medical science

Peter Hotez and the public health issue of online harassment

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Cancer drug shortages should be causing more outrage

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

The high cost of giving birth even with insurance

NIH launches clinical trials and new research office for long Covid

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: What happened with Sarepta's Duchenne data

hotspot

What to expect as Trump is arraigned on his Jan 6. indictment

The pink breast cancer awareness ribbon needs a redesign

Readout Newsletter: What happened with Sarepta's Duchenne data

Readout Newsletter: New research from Sanofi, Regeneron, etc.

FDA has safety concerns on CRISPR

Senate panel to vote on hospitals, PBMs, prisoner care

hotspot

knowledge

hotspot

hotspot